Rappel de Device Recall FlowCOUPLER

Selon U.S. Food and Drug Administration, ce/cet/cette rappel concerne un dispositif en/au/aux/à United States qui a été fabriqué par Baxter Healthcare Corporation.

Qu'est-ce que c'est?

Une correction ou un retrait opéré par un fabricant afin de répondre à un problème causé par un dispositif médical. Les rappels surviennent lorsqu'un dispositif médical est défectueux, lorsqu'il pourrait poser un risque pour la santé, ou les deux à la fois.

En savoir plus sur les données ici
  • Type d'événement
    Recall
  • ID de l'événement
    68789
  • Classe de risque de l'événement
    Class 2
  • Numéro de l'événement
    Z-2126-2014
  • Date de mise en oeuvre de l'événement
    2014-07-11
  • Date de publication de l'événement
    2014-07-29
  • Statut de l'événement
    Terminated
  • Pays de l'événement
  • Date de fin de l'événement
    2015-05-27
  • Source de l'événement
    USFDA
  • URL de la source de l'événement
  • Notes / Alertes
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Notes supplémentaires dans les données
    Flowmeter, blood, cardiovascular - Product Code DPW
  • Cause
    Baxter healthcare is recalling the flowcoupler device because there is a possibility that some units may not maintain electrical continuity during handling intra-operatively and post-operatively, resulting in a loss of doppler signal. this may result in the inability to monitor anastomotic patency, with the possibility that blood flow may not be appropriately monitored.
  • Action
    Synovis Micro Companies Alliance, Inc. (a subsidiary of Baxter International Inc.) sent an Urgent Medical Device Recall letter on July 11, 2014, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. The letter informs the customers that the recall is being conducted as a precautionary measure due to the possibility that some units may not maintain electrical continuity during handling intra-operatively and post-operatively, resulting in a loss of Doppler signal. This may result in the inability to monitor anastomotic patency, with the possibility that blood flow may not be appropriately monitored. The recall letter informs the customers of the safety risk and and actions to be taken. Customers with questions about the recall are instructed to contact the Synovis MCA Customer Service unit at (800) 510-3318 or (205) 941-0111.

Device

  • Modèle / numéro de série
    Lot Number SPSGT14-02B0027a SPSGT14-04D0005 SPSGT14-04D0023  SPSGT13-10J0016 SPSGT13-11K0041 SPSGT13-12L0008 SPSGT14-01A0009  SPSGT14-02B0026 SPSGT14-04D0015 SPSGT14-04D0026  SPSGT13-10J0017 SPSGT13-11K0039 SPSGT13-11K0042 SPSGT13-12L0015 SPSGT14-01A0028  SPSGT14-02B0028 SPSGT14-02B0033 SPSGT14-04D0014 SPSGT14-04D0027 SPSGT14-05E0005  SPSGT13-10J0018 SPSGT13-11K0040 SPSGT13-12L0007 SPSGT13-12L0012 SPSGT14-01A0027   Part No. 5151-01200-010 5151-01200-010 5151-01200-010   5151-01200-011 5151-01200-011 5151-01200-011 5151-01200-011   5151-01250-010 5151-01250-010 5151-01250-010   5151-01250-011 5151-01250-011 5151-01250-011 5151-01250-011 5151-01250-011   5151-01300-010 5151-01300-010 5151-01300-010 5151-01300-010 5151-01300-010   5151-01300-011 5151-01300-011 5151-01300-011 5151-01300-011 5151-01300-011
  • Classification du dispositif
  • Classe de dispositif
    2
  • Dispositif implanté ?
    No
  • Distribution
    Worldwide Distribution - USA (nationwide) and the countries of United Kingdom, Germany, Sweden, Spain, Israel and Denmark.
  • Description du dispositif
    FlowCOUPLER. An implantable device that is used to detect blood flow in vessels. Used in the end-to-end anastomosis of veins and arteries normally encountered in microsurgical and vascular reconstructive procedures. The FlowCOUPLER System is intended to detect blood flow and confirm vessel patency intra-operatively and post-operatively at the anastomotic site. Baxter Healthcare.
  • Manufacturer

Manufacturer

  • Adresse du fabricant
    Baxter Healthcare Corporation, 1 Baxter Way, Westlake Village CA 91362-3889
  • Société-mère du fabricant (2017)
  • Source
    USFDA